🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robert J. Fox

Cleveland Clinic

ORCID: 0000-0002-4263-3717
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.5Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS

Neurology Clinical Practice(2020)10.1212/cpj.0000000000000800
Top 15%
1.4DataRank
Top 15%21 citations

John Rose, Enrique Álvarez, Amit Bar‐Or, Helmut Butzkueven, Robert J. Fox +17 more

Papers

Driven by 12 papers — median percentile 54. Top paper: “Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial”.

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

The Lancet Neurology(2021)10.1016/s1474-4422(21)00237-4
N/A
4.3DataRank · unranked
192 citations

Douglas L. Arnold, Patrick Vermersch, Amit Bar‐Or, Robert J. Fox, André Palma da Cunha Matta +48 more

Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS

Neurology Clinical Practice(2020)10.1212/cpj.0000000000000800
Top 15%
1.4DataRank
Top 15%21 citations

John Rose, Enrique Álvarez, Amit Bar‐Or, Helmut Butzkueven, Robert J. Fox +17 more

Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis

Multiple Sclerosis Journal(2020)10.1177/1352458520964409
N/A
1.1DataRank · unranked
26 citations

Janel Fedler, Peter K. Kaiser, Cindy Novalis, Jeff Schneebaum, Elizabeth Klingner +10 more

Effect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosis

Multiple Sclerosis Journal(2023)10.1177/13524585231187289
N/A
0.386DataRank · unranked
6 citations

Yufan Zheng, Kedar Mahajan, Jeffrey A. Cohen, Robert J. Fox, Daniel Ontaneda +1 more

Fourteen-year serial MRIs of patients with mild and severe courses of MS

Neurology Clinical Practice(2020)10.1212/cpj.0000000000000695
Top 78%
0.104DataRank
Top 78%1 citations

Richard A. Rudick, Daniel Ontaneda, Robert J. Fox, Bruce D. Trapp, Elizabeth Fisher +1 more

Tolebrutinib Phase 2b Long-Term Extension Study

Neurology Open Access(2025)10.1212/wn9.0000000000000028
N/A
0DataRank · unranked
4 citations

Robert J. Fox, Douglas L. Arnold, Sana Syed, Deborah Dukovic, Wendy Vargas +6 more

Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective

JAMA Neurology(2020)10.1001/jamaneurol.2020.4689
N/A
0DataRank · unranked
66 citations

Paolo Preziosa, Frederik Barkhof, Declan Chard, Nicola De Stefano, Robert J. Fox +13 more

Automated identification of older adults at risk for cognitive decline

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2025)10.1002/dad2.70136
N/A
0DataRank · unranked
0 citations

Olivia Hogue, Saket Saxena, Anita D. Misra‐Hebert, Alex Milinovich, Michael B. Rothberg +6 more

Seeking progress in disease modification in Parkinson disease

Parkinsonism & Related Disorders(2021)10.1016/j.parkreldis.2021.09.006
N/A
0DataRank · unranked
15 citations

Jesse M. Cedarbaum, Ted M. Dawson, E. Ray Dorsey, Carlos Alberto Faraco, Howard J. Federoff +18 more

Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype

Annals of Clinical and Translational Neurology(2021)10.1002/acn3.51251
N/A
0DataRank · unranked
14 citations

Janel Fedler, Jon Yankey, Elizabeth Klingner, Dixie Ecklund, Christopher Goebel +8 more

Characterizing multiple sclerosis disease progression using a combined structural and functional connectivity metric

Magnetic Resonance Imaging(2023)10.1016/j.mri.2023.07.016
N/A
0DataRank · unranked
3 citations

Robert J. Fox, Ken Sakaie, James Bena, T. Harvey, Paola Raska +3 more

Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis

Multiple Sclerosis Journal(2024)10.1177/13524585231224702
N/A
0DataRank · unranked
33 citations

Bhaskar Thoomukuntla, James Bena, Jeffrey A. Cohen, Robert J. Fox, Daniel Ontaneda +1 more